Skyscape Web Viewer : Targeted Cancer Therapy A Handbook for Nurses : Main Index

View All
bFGF,
Bisphosphonate-related osteonecrosis of the jaw Pharmacologic Management staging and recommendations for treatment of
Bisphosphonates Bone Metastasis denosumab vs. pamidronate Pharmacologic Management References (Chapter 4) zoledronic acid
Blasco, M. A.
Blastula
BMD,
BMPs,
BMS-690514
Bone building and breakdown, process of
Bone metastasis Bone Metastasis Chapter 4. Targeting the Microenvironment: Bone Metastasis, Apoptosis, DNA Repair, and Mitosis FDA approved drugs for Introduction new understanding of microenvironment and osteoclast stimulation local factors, 256 systemic factors pharmacologic management Pharmacologic Management process of, 257-262 breast cancer and, 258-259 multiple myeloma and, 260-262 prostate cancer and References (Chapter 4)
Bone mineral density, breast cancer, prostate cancer, bony metastases and
Bone morphogenetic proteins, osteoblastic proliferation and differentiation and
Bone remodeling Bone Metastasis Glossary Hepatocyte Growth Factor (Hgf/C-Met) Receptor Pathway Targets References (Chapter 4)
Bone-resorbing osteoclasts, activation of, breast cancer cells and
Bones, physiology of
Bortezomib (Velcade)
Bosutinib (SKI-606)
BRAF Application Of The Hallmarks Of Cancer Membrane-Bound Receptor Kinases (E.g., Egfr, Her2, Hgf/C-Met, Igfr Pathways) Protein Dynamics: Heat Shock Proteins and Ubiquitin - Proteasome Inhibitors Protein Kinase Signaling Pathways References (Chapter 2)
BRAT diet,
BRCA1 (breast cancer 1, early onset) Glossary PARP1 and synthetic lethality and
BRCA2 Application Of The Hallmarks Of Cancer Dna Repair Gene Mutations: Opportunities From Synthetic Lethality Glossary PARP1 and synthetic lethality and
Breakpoint cluster region
Breast cancer
Bronchodilators Membrane-Bound Receptor Kinases (E.g., Egfr, Her2, Hgf/C-Met, Igfr Pathways) Monoclonal Antibodies Nursing Considerations and Drug Information
BSI-201 Dna Repair Gene Mutations: Opportunities From Synthetic Lethality Mitotic Kinase Inhibitors References (Chapter 4)
Bu, G.
Bucket brigade proteins Application Of The Hallmarks Of Cancer Intracellular Signaling Kinases (E.g., Src, P13k/Akt/Mtor; Mapk; Sonic Hedgehog Pathways) Membrane-Bound Receptor Kinases (E.g., Egfr, Her2, Hgf/C-Met, Igfr Pathways) Protein Kinase Signaling Pathways
CA4P Antiangiogenic Drug Therapy Hypoxia-Inducible Factor, Mtor, and Angiogenesis
CAFs,
Calcineurin inhibitors, temsirolimus and